在犬群中进行卡博普拉丁的临床剂量调整的人口药理动力学建模
Jérémy Béguin1,2, Sarra Mahfoudhi3, Marie Uzel1
1Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.
BMC veterinary research
|December 24, 2024
概括
通过考虑肌素水平和中和状态,可以改善狗的碳白剂量. 这种药理动力学模型比标准剂量更好地预测血小板减少,从而有可能最大限度地降低毒性.
科学领域:
- 兽医药理学 兽医药理学 兽医药理学
- 药理动力学 药理动力学
- 在瘤学瘤学.
背景情况:
- 卡博普拉丁是用于治疗犬类固体瘤的广泛使用的化疗.
- 目前的剂量 (300 mg/m2) 依赖于经验数据,不同于人体患者的剂量根据肌素清除量进行调整.
- 卡博普拉丁在狗中的药理动力学尚不清楚.
研究的目的:
- 在狗中描述卡博普拉丁的药理动力学.
- 为了研究协变量的影响,如肌素血度和中和状态.
- 开发一个模型来预测碳金诱导的骨髓毒性.
主要方法:
- 一个单间模型被用来分析16只狗的血碳烯度.
- 高性能液体染色学/质谱学 (HPLC/MS) 确定了自由碳烯的含量.
- 非线性混合效应建模 (Monolix®) 纳入了共变量.
主要成果:
- 血肌氨酸度和绝育状态是影响卡博普拉丁药理动学的显著共变量.
- 经共变量调整后,中位人口清除值为3.62 L/h/kg,分布量为3.93 L/kg.
- 模型预测的曲线下的面积 (AUC) 预测的血小板减少比剂量更好 (r2=0.73,p=0.002).
结论:
- 血肌和中毒状态是卡博普拉丁在狗中的药物动力学变异性的关键因素.
- 根据这些共变量进行剂量调整可能会降低血小板毒性.
- 这种药理动力学模型提供了一个更精确的方法,用于卡博普拉丁治疗犬类瘤学.
关键词:
碳烯金是碳烯金中的一种.狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗建模模型 建模模型功能 功能 功能血小板减少症 (Thrombocytopenia) 是一个严重的疾病.更多相关视频
相关概念视频
Nonlinear Pharmacokinetics: Overview
191
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
191
Analysis of Population Pharmacokinetic Data
190
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
190
Pharmacokinetic Models: Comparison and Selection Criterion
19
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
19
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
34
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
34
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
43
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
43
One-Compartment Open Model for IV Bolus Administration: General Considerations
110
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
110


